arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Progyny, Inc.

PGNY
$34.43 ▲ +4.38 (+14.58%) at close
Healthcare ·Services-Misc Health & Allied Services, NEC ·USServices-Misc Health & Allied Services, NEC
9 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
69
Health
Good
Neutral
auto_awesome

Analytical Summary

Progyny, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $2.9B
Dividend Yield —
Revenue Growth 10.4% ↗
Op. Margin 6.6% ↗
ROIC 10.1% ↘
FCF / Share $2.24 ↗
Trailing P/E 50.6x
Price / Book 5.6x
FCF Yield 6.5%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

9-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.29B
↑ +10.4% —
Net Income Profit after all expenses
$58.52M
↑ +7.7% —
Operating Margin Operating profit as % of sales
6.6%
↑ +14.5% 47th
FCF / Share Free cash flow per share
$2.24
↑ +17.9% —

Health Breakdown

Profitability →
56
Returns ↓
72
Cash Quality ↑
92

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 9 years · 35 quarters